维生素C对低氧诱导乳腺癌干细胞的调节作用
Masoumeh Kazemi1,2, Soheila Montazersaheb3, Mina Noroozpour4
1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Advanced pharmaceutical bulletin
|November 29, 2023
概括
高剂量的维生素C可能有助于通过减少癌症干细胞 (CSCs) 的增殖和干性来对抗癌症干细胞. 这项研究研究了维生素C.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 癌症干细胞 (CSCs) 呈现耐药性,这构成了治疗挑战.
- 在晚期癌症阶段观察到维生素C缺乏,这表明其潜在的治疗作用.
- 缺氧是已知的CSC特征的诱导因素.
研究的目的:
- 研究高剂量维生素C对低氧MCF7细胞基因表达的影响,模仿CSC条件.
- 分析维生素C对特定基因的影响,这些基因与茎状和亡有关:HIF-1α,NF-κB1,BAX和DNMT1.
主要方法:
- MCF7细胞受到低氧作用以诱导CSC特征.
- 在维生素C治疗后,测量了HIF-1α,NF-κB1,BAX和DNMT1基因的表达水平.
- 分析的重点是乳房CSC群体和基因表达模式的变化.
主要成果:
- 维生素C治疗减少了CSCs中的增殖和干部.
- 维生素C诱导了亡标志物BAX的表达.
- 维生素C减弱了树干性标记物NF-κB1和DNMT1.1的表达.
结论:
- 维生素C显示出作为癌症治疗的辅助疗法的潜力.
- 维生素C可能会在癌症治疗期间抑制CSC刺激.
- 进一步研究维生素C在癌症治疗中的作用是有必要的.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K


